Our partners

Resource Information
Topics: 
Partners
Partnership

Our partners' expertise and engagement are fundamental to drive long-term and measurable changes in cancer control for the benefit of the global cancer community. 

Click on the logos here below to see more information about each partner.

Patrons programme
ACS
American Cancer Society

The American Cancer Society is a global grassroots force of 2.5 million volunteers saving lives in every community. As the largest voluntary health organization, the Society’s efforts have contributed to a 25 percent decline in the cancer death rate in the U.S. since 1991, driven by less smoking, better treatments, and earlier detection. The American Cancer Society is finding cures as the United States largest private, not-for-profit investor in cancer research, ensuring people facing cancer have the help they need and continuing the fight for access to quality health care, lifesaving screenings and more. The Society’s global outreach efforts promote prevention and healthy living, reduce pain and suffering from cancer and help support cancer organizations in low and middle income countries, and provide a platform for advocacy and patient support in nearly 30 countries.

CDC Centers for Disease Control and Prevention
CDC Centers for Disease Control and Prevention

CDC works 24/7 to protect America from health, safety and security threats, both foreign and in the U.S. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same. CDC increases the health security of our nation. As the nation’s health protection agency, CDC saves lives and protects people from health threats. To accomplish our mission, CDC conducts critical science and provides health information that protects our nation against expensive and dangerous health threats, and responds when these arise.

Fondation Philantropia
Fondation Philantropia

An umbrella foundation associated with the bank Lombard Odier and a registered charity, Fondation Philanthropia has been helping its donors bring their philanthropic initiatives to fruition in all areas of social responsibility since 2008. It provides philanthropic expertise and support to those who wish to develop a philanthropic project in line with their background, desires and ambitions. The Foundation offers its donors a legal, financial and philanthropic framework for made-to-measure projects.

The Foundation now operates more than 20 personal funds and has received over 115 million Swiss francs in donations, of which over a third has already been distributed or committed. Its donors have been highly committed to the fight against cancer, with over 15 million spent on the cause.

MSD be well
MSD (Merck & Co)

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bring forward medicines and vaccines for the world’s most challenging diseases.  MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J., USA. Through their prescription medicines, vaccines, biologic therapies, and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrates their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.

National Cancer Institute (NCI)
National Cancer Institute (NCI)

The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. The NCI coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.

Pfizer
Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products. We work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.

Roche logo
Roche

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims for improving patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide.

Champions programme
Vanguard
ACS
American Cancer Society

The American Cancer Society is a global grassroots force of 2.5 million volunteers saving lives in every community. As the largest voluntary health organization, the Society’s efforts have contributed to a 25 percent decline in the cancer death rate in the U.S. since 1991, driven by less smoking, better treatments, and earlier detection. The American Cancer Society is finding cures as the United States largest private, not-for-profit investor in cancer research, ensuring people facing cancer have the help they need and continuing the fight for access to quality health care, lifesaving screenings and more. The Society’s global outreach efforts promote prevention and healthy living, reduce pain and suffering from cancer and help support cancer organizations in low and middle income countries, and provide a platform for advocacy and patient support in nearly 30 countries.

Amgen logo
Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Astellas
Astellas

The Astellas Group aims to become a R&D-driven global pharmaceutical company contributing to people’s health. Astellas’s business philosophy has three elements — raison d'être, mission and beliefs. This business philosophy expresses the company’s aim to contribute to the health of people around the world through the provision of highly effective and trustworthy pharmaceuticals, while continuously increasing the Company's enterprise value.

Bristol-Myers_Squibb_logo.png
Bristol-Myers Squibb (BMS)

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.

CDC Centers for Disease Control and Prevention
CDC Centers for Disease Control and Prevention

CDC works 24/7 to protect America from health, safety and security threats, both foreign and in the U.S. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same. CDC increases the health security of our nation. As the nation’s health protection agency, CDC saves lives and protects people from health threats. To accomplish our mission, CDC conducts critical science and provides health information that protects our nation against expensive and dangerous health threats, and responds when these arise.

DKG
DKG Krebsgesellschaft

The German Cancer Society (DKG) is the largest scientific and specialist oncology company in Germany with headquarters in Berlin. They are engaged in cancer care on the basis of evidence-based medicine, interdisciplinary and consequent quality standards. In total, DKG has about 7600 members, organised in 24 working groups, 16 regional cancer societies and 34 sponsors from research-based pharmaceutical industries, scientific publishers and health insurances. Since cancers need to be cross-treated and researched, their members are not only medical doctors of all sections, but also basic researchers, medical technical assistants, nurses, psychologists and other professionals who work on cancer.

DKG specialises in certification of oncological care institutions, development of clinical practice guidelines, coordination of guidelines in the framework of the German Guideline Program of Oncology (GGPO), development and transfer of oncological knowledge, and improvement of information given to patients.

Fondation Philantropia
Fondation Philantropia

An umbrella foundation associated with the bank Lombard Odier and a registered charity, Fondation Philanthropia has been helping its donors bring their philanthropic initiatives to fruition in all areas of social responsibility since 2008. It provides philanthropic expertise and support to those who wish to develop a philanthropic project in line with their background, desires and ambitions. The Foundation offers its donors a legal, financial and philanthropic framework for made-to-measure projects.

The Foundation now operates more than 20 personal funds and has received over 115 million Swiss francs in donations, of which over a third has already been distributed or committed. Its donors have been highly committed to the fight against cancer, with over 15 million spent on the cause.

Fondation Sanofi Espoir
Fondation Sanofi Espoir

Created in 2010 by Sanofi Group to fortify its international solidarity and make its commitment clearer to all stakeholders, the Sanofi Espoir Foundation aims to reduce healthcare inequalities and poverty among the world’s poorest populations. Its action lines are focused on three priority areas: fighting childhood cancer in low-income countries, Improving maternal and newborn healthcare and delivering access to care for the most vulnerable social groups, particularly in France. The Sanofi Espoir Foundation naturally responds to humanitarian emergencies, but focuses primarily on long term partnerships to act on such recurrent issues as education and prevention, training and access to care.

ICONGROUP__CMYK_Logo.png
ICON Group

Icon Group is a leading provider of cancer care across Australasia. Icon believes in bringing the best cancer treatment possible, to as many people as possible, as close to home as possible. They do this through leveraging the latest technology, collaborating with like-minded partners and investing in outstanding people.

MERCK_LOGO_Blue_RGB.png
Merck KGaA

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.  Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the “Merck” name and brand except in the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

MSD be well
MSD (Merck & Co)

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bring forward medicines and vaccines for the world’s most challenging diseases.  MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J., USA. Through their prescription medicines, vaccines, biologic therapies, and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrates their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.

National Cancer Institute (NCI)
National Cancer Institute (NCI)

The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. The NCI coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.

Novartis_Oncology_trans.png
Novartis Oncology

Novartis Oncology is a global leader in transforming outcomes for people with cancer. We offer a wide range of innovative therapies to help meet patient needs and have one of the strongest, most productive pipelines in the industry. Our research is driven by a distinctive scientific and clinical strategy focused on precision oncology – understanding how cancer develops on a genomic level and developing drugs that hone in on those targets.

Pfizer
Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products. We work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.

Roche logo
Roche

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims for improving patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide.

Swiss Cancer League
Swiss Cancer League

The Swiss Cancer League is a national, charitable, private organisation, founded in 1910. It is the Berne-based headquarter of an association of 19 regional cancer leagues. The Swiss Cancer League covers all aspects of cancer, with the aim of ensuring that fewer people develop cancer, fewer people suffer and die from the consequences of cancer and more people can be treated successfully. The organisation supports innovative cancer research projects, increases public awareness of prevention measures and is committed to early diagnosis and treatment. One of its first concerns is to ensure high-quality advice and psychological support for all cancer patients and survivors and their caretakers. The Swiss Cancer League also supports other cancer control organisations in low income countries.

UICC Japan
UICC Japan

The Japan National Committee for UICC is a group of Japanese organisations that are members of the Union for International Cancer Control (UICC), gathered to support the UICC to strive to realise the World Cancer Declaration. Currently UICC-Japan is composed of 29 full Japanese UICC members, including major cancer specialists in Japan, cancer centres, research institutes, research funds, hospitals and cancer associations.

UPMC_3_S_RGB_Tag.jpg
UPMC - Life changing medicine

UPMC is a global academic medical center headquartered in Pittsburgh, Pennsylvania, United States and it is   ranked No. 12 in the U.S. News & World Report Honor Roll of America’s Best Hospitals. UPMC has many   clinical and research centers of excellence, including UPMC CancerCenter which is an NCI Designated Comprehensive Cancer Center. In partnership with the University of Pittsburgh Cancer Institute, it maintains rigorous standards in clinical and research quality, consistency, and outcomes at more than 50 outpatient cancer centers. With years of experience, UPMC is helping to develop new models of accountable, cost-efficient, and patient-centered care.

For nearly two decades, UPMC has shared its expertise with public and private partners spanning three continents in cancer center projects including operations management, quality and safety, training, clinical pathways, clinical research, facility and construction management and program design. Through projects in countries such as Italy, Singapore, China, Colombia, and Ireland, UPMC’s collaborations support the transformation of health care so that patients receive the best-possible cancer care, close to home.

Varian
Varian

Varian Medical Systems’ mission is to focus energy on saving lives. To meet this challenge, they equip the world with new tools for fighting cancer. Since the 1950s they have been producing tools that harness the power of X-ray energy to benefit humankind. Varian’s history is one of pioneering developments in the fields of radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing. Today, they have a robust product portfolio and long-standing relationships with many of the world’s leading clinicians. As Varian continues to grow, their staff of over 6,500 people in 70 sales and support offices around the globe is developing innovative, cost-effective solutions that help make the world a healthier place.

WCRF
World Cancer Research Fund International (WCRF)

World Cancer Research Fund International is the world’s leading authority on cancer prevention research related to diet, weight and physical activity. Their vision is to live in a world where no one develops a preventable cancer. On behalf of the cancer prevention charities in the World Cancer Research Fund network, WCRF commissions research from leading institutions around the world into the effects of diet, nutrition, body fatness, physical activity on cancer and cancer survival. This research aims to fill the current gaps in scientific knowledge.

Benefactors
ASCO.png
American Society for Clinical Oncology (ASCO)

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organisation of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organisation, the Conquer Cancer Foundation. 

ASCP_ST.png
American Society for Clinical Pathology (ASCP)

The American Society for Clinical Pathology (ASCP) is the world’s largest professional membership organisation for pathologists and laboratory professionals. In addition to their educational and certification missions around the world, they maintain a very active global health delivery program focused on laboratory strengthening in all aspects. Through their 10 year + work with PEPFAR, they have improved HIV-related testing and access in ~20 countries, trained more than 3000 individuals, and continue to deliver innovated diagnostics their partners. The Cancer Diagnostics and Treatment in Africa Initiative, created and led by ASCP, aims for 100% access to diagnostics for patients with cancer through on-site assessment, implementation planning, and, ultimately, connectivity to experts around the world through telepathology. With more than 100,000 members, the society’s influence has guided the application and evolution of the pathology and laboratory medicine specialty since 1922. ASCP is leading the way in global health pathology.

Bayer_Cross_4c_100801_trans.png
Bayer

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen.

CRUK
Cancer Research UK

Cancer Research UK is the world’s largest independent funder of cancer research. Its vision is to bring forward the day when all cancers are cured. Since 1902 CRUK has found new ways to prevent, diagnose and treat cancer. CRUK-funded scientists’ pioneered early radiotherapy, developed some of the world’s top cancer drugs and discovered the tumour suppressor gene, p53. Its work has saved millions of lives across the world. CRUK invests $500m annually in world-leading research across all 200 different types of cancer, working with partners in Europe, North America and Asia to accelerate research progress. It provides information to those affected by cancer, works to increase cancer awareness, and uses its powerful, independent voice to keep cancer at the top of the political agenda. CRUK funds some of the world’s leading experts in tobacco research and is a key player in international tobacco control. It became a full UICC member in 1986.

Logo-Cancerfonden.png
Cancerfonden

Founded in 1951 to support cancer research, the Swedish Cancer Society is an independent non-profit organization with the vision of finding cures for cancer. The overall aim of the Society is to achieve a higher survival rate and a reduction in the incidence of cancer. Their main task is to raise and distribute money for cancer research. As one of the largest financiers of cancer research in Sweden, the Swedish Cancer Society essentially acts as a national research council. Thanks to the organization’s extensive knowledge about cancer, the Swedish Cancer Society is also active in areas such as public opinion and spreading knowledge about cancer, as well as results of cancer research.

Elekta logo
Elekta

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Their advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology.

Their treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm

laligue_web.png
French league against cancer

"La Ligue Nationale contre le Cancer" (French League Against Cancer) is a public interest association founded in 1918, after World War I, when cancer was recognized to be a spreading epidemic. The League is a spokesperson for patients and their relatives and works with different organizations to promote the rights of patients and users of the health system. Since its creation, the League has developed into a strong network, leading the fight against cancer on four levels: funding research, promoting screening and prevention, addressing social questions and supporting patients and their loved ones. The League is a federation of 103 departmental committees that are active in relaying the League’s missions throughout the French territory (including overseas). The League has more than 640,000 members, 13,000 volunteers and 400 salaried staff who keep the network active by leading the fight against cancer on a daily basis.

Jaermann_Stuebi_TimepieceOfGolf_Logo_gruener_Greif.png
Jaermann & Stubi

Jaermann & Stübi is a luxury Swiss timepiece maker headquartered in Rapperswil. The golf watches are developed and produced in the company’s atelier in the Swiss Jura based Le Locle. All pieces are hand crafted on a small series and numbered individually, making these watches some of the most sought after in Switzerland. J&S specializes in premium timepieces with additional functions for golfers and collaborates with St Andrews Links, the Home of Golf, and Seve Ballesteros foundations, among other notable golfing personalities, such as Sir Nick Faldo, Ben Crenshaw and Ian Woosnam.

PCF Logo - Prevent Cancer Foundation Vertical_2016.jpg
Prevent Cancer Foundation

The mission of the Prevent Cancer Foundation® is saving lives across all populations through cancer prevention and early detection. The Prevent Cancer Foundation® is one of the leading voluntary health organizations in the U.S. and the only U.S. non-profit focused solely on cancer prevention and early detection. Founded in 1985, it has catapulted cancer prevention to prominence and fulfils its mission through research, education, outreach and advocacy. The Foundation’s vision is to Stop Cancer Before It Starts!®

Sanofi
Sanofi

Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.

UNICANCER
UNICANCER

The UNICANCER Group brings together the French Comprehensive Cancer Centers (FCCC), promotes their cancer research organisation and pools resources and competencies to give a new dynamic to patient care. Since their creation in 1945, the French Comprehensive Cancer Centers have held a special place in the French health care system. These private, non-profit establishments are entirely devoted to fighting cancer with a view to public service. They have a threefold mission: patient care, research and teaching. UNICANCER builds on the historical community of the FCCC and accentuates what has always been their strength: cooperating and creating synergies between different teams within the network.

Wiley.png
Wiley

Wiley is a global provider of content and content-enabled workflow solutions in areas of scientific, technical, medical, and scholarly research; professional development; and education. Their core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.
 

Partners
AbbVie
Abbvie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries.

Accuray 2015 RGB
Accuray

Accuray Incorporated invents, manufactures and supports a complete portfolio of radiation therapy and radiosurgery platforms, including the CyberKnife®, TomoTherapy®, Radixact™ and Onrad™ Systems, for treating multiple forms of cancer including the most common or complex forms of cancer diagnosed throughout the world. They surround their platforms with a full range of expert services that their customers confidently leverage to drive the outcomes that matter most to them — optimizing patient care, enabling staff efficiency and sustaining practice prosperity. Accuray designs its tumor treatment solutions in collaboration with oncology professionals who share their goals of continuously improving care and helping patients live long and healthy lives. They work passionately to create a future without the fear, pain or human suffering of cancer.

AstraZeneca logo
AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.  

Boehringer_Ingelheim.png
Boehringer Ingelheim (BI)

Through scientific innovation and collaboration, Boehringer Ingelheim is committed to discovering and developing novel cancer treatments for patients in areas of high unmet medical need. Their oncology research is driven by a passion to improve the lives of patients who are battling cancer and a determination for cancer to eventually be treated as a chronic condition. They seek out strong partnerships and remain dedicated to expanding our portfolio of treatments in both solid tumours and haematological cancers. Boehringer Ingelheim prides in their unique approach to research and discovery which is currently focused on angiogenesis inhibition, signal transduction inhibition, cell-cycle kinase inhibition, immunotherapy, apoptosis, epigenetics and protein homeostasis.

Canadian Cancer Society
Canadian Cancer Society

The Canadian Cancer Society is a national, community-based organisation of more than 140,000 volunteers whose mission is the eradication of cancer and the enhancement of the quality of life of people living with cancer.

Canadian Partnership Against Cancer (CPAC) Logo
Canadian Partnership Against Cancer (CPAC)

The Canadian Partnership Against Cancer is an independent organisation funded by the federal government to accelerate action on cancer control for all Canadians. The Partnership works with cancer experts, charitable organisations, governments, cancer agencies, national health organisations, patients, survivors and others to achieve their shared goal of a future in which fewer Canadians get cancer, fewer die from it and those living with the disease have a better quality of life. The Partnership’s work spans the cancer control continuum, from prevention and screening to research and supportive care. Their collaborative approach is mindful of the patient voice, and strives to be culturally responsive to the needs of local communities.

Cancer Council Australia Logo
Cancer Council Australia

Cancer Council Australia is Australia’s largest non-government, not-for-profit cancer control organisation. Cancer Council is Australia’s leading non-government funder of cancer research, prevention and education programs, patient support and advocacy. Services to the community include the provision of a national telephone information and support line, public education programs aimed at reducing cancer risk and the development of clinical practice guidelines for health professionals and consumers.

Cancer Society of Finland.png
Cancer Society of Finland

Founded in 1936, the Cancer Society of Finland is the largest patient and public health organisation in Finland as well as being an expert organisation nationally. The aim of CSF is to prevent cancer, promote health and ensure a good quality of life for people with cancer. The CSF comprises of 12 regional cancer societies and six national patient organisations. The CSF’s member societies are independent actors that adhere to commonly agreed values and working principles. Activities are based on the results of scientific research, which is funded through grants offered by the Cancer Foundation Finland sr and the Foundation for the Finnish Cancer Institute sr. The Finnish Cancer Registry is a statistical and epidemiological cancer research institute that has run a database of all cases of cancer in Finland since 1952.

Celgene_trans.png
Celgene

Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. At Celgene, we seek to deliver truly innovative and life-changing treatments for our patients.

CACA.jpg
Chinese Anti-Cancer Association (CACA)

Established in 1984, the Chinese Anti-Cancer Association (CACA) is a non-government and non-profit organisation with a mission to unite people involved in all branches of oncology with a shared interest in fighting cancer. CACA is dedicated to improving cancer control in China through increasing the survival rates, and decreasing the incidence and mortality rates of cancer. CACA plays an important role in promoting academic exchange, organising public education, establishing collaboration with international cancer societies, and providing data and advice to the Chinese government for making strategies and policies on cancer control. The branches consist of 45 professional societies, 47 full membership organisations, and 30 local anti-cancer associations with a total membership exceeding 47,000.

Heng-Rui_trans.png
Heng Rui Pharmaceuticals

Jiangsu Hengrui Medicine Co., Ltd. is a frontrunner of China’s innovative medicine, engaging in the research, development, promotion, production, and sales of medicines in China. They focus on fulfilling the unmet clinical demands, promoting innovation in technology, and servicing the health of humanity. They specialise in the R&D of new medicines in the areas of antineoplastics, endocrine system, cardiovascular, and the immune system. Hengrui Medicine is committed to producing high quality medicines to help more patients have access to better and affordable medical resources. 

Iba logo
Iba

IBA is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide. IBA has installed systems across the world.

Johnson & Johnson logo
Johnson & Johnson

Caring for the world one person at a time inspires and unites the people of Johnson & Johnson. They embrace research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Their approximately 126,400 employees at more than 230 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

For 130 years, Johnson & Johnson has been committed to improving the health of individuals, families and communities around the world, including the most vulnerable populations. Today, their vibrant, entrepreneurial and committed employees bring business acumen and their collaborative spirit to help solve some of the most complex global health problems. By harnessing their collective breadth and scale, and their employees’ passion and purpose, Johnson & Johnson strives to advance health care and positively impact the lives of all people.

Kreftforeningen_NCS_logo_rgb_2.jpg
Norwegian Cancer Society

NCS is an active civil society actor which contributes to targeted efforts in cancer information, prevention, advocacy, research, care, and international cooperation. Their activities are funded thanks to the contributions of its members, bequests, and allocations from the national lottery funds. Their main objectives are to: Contribute to ensure that fewer people develop cancer (reduction of the prevalence and incidence of cancer), Contribute to more people surviving cancer, Ensure the best quality of life for people affected by cancer (cancer patients and their relatives). The vision of NCS is: “Together we create hope”.

Teva Oncology logo
Teva Oncology

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by approximately 200 million patients in 100 markets every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has the world-leading innovative treatment for multiple sclerosis as well as late-stage development programs for other disorders of the central nervous system, including movement disorders, migraine, pain and neurodegenerative conditions, as well as a broad portfolio of respiratory products. Teva is leveraging its generics and specialty capabilities in order to seek new ways of addressing unmet patient needs by combining drug development with devices, services and technologies. Teva's net revenues in 2016 were $21.9 billion.

The-Faraday-Project-Logotype-RGB.jpg
The Faraday Project

The Faraday Project is a Parisian based fashion brand which combines quality, comfort and technology to design and produce functional clothes for urban pioneers. Specialized in menswear, all products in the collections feature the best raw materials from around the world, anti sniffing protections and act as a shield against electromagnetic waves (reducing cancer risks).

Want to join our Champions Programme and play a key role in advancing our global fight against cancer?

For more information, please download our Together we can or contact directly:

Lorenzo Boffi, Partnership Development Manager: boffi@uicc.org

Last update: 
Monday 26 June 2017
Share
Latest partners news
© Moonshine Agency Pty Ltd - Life before death
21 June 2017
  • Advocacy
  • Members
  • Partners

A new collaboration to increase access to lifesaving cancer treatment in Africa

American Cancer Society and Clinton Health Access Initiative announce collaborations with Pfizer and Cipla to increase access to lifesaving cancer treatment in Africa.

www.C3prize.com
20 June 2017
  • Capacity building
  • Members
  • Partners

The Astellas Oncology C3 Prize returns for a second year

UICC partner Astellas Oncology is calling for submissions for the C3 Prize aiming to inspire and support innovative ideas for cancer care with $100,000 in grants.  

161103_2016WCC_WEB_HIGHLIGHTS-42.jpg
15 June 2017
  • Convening
  • Capacity building
  • Advocacy

2018 WCC video: discover what to expect in Kuala Lumpur

Find out why Congress participants recommend the only forum dedicated to advancing cancer control globally and nationally...